Laixing Wang

Dr. Laixing Wang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2017 in Photochemical & Photobiological Sciences
Verified
Journal Article
Closed access
PDF file
WZwei zhu
wei zhu
YGYing-Hua Gao
Ying-Hua Gao
CSChun-Hong Song
Chun-Hong Song
ZLZhi-Bin Lu
Zhi-Bin Lu
TNTabbisa Namulinda
Tabbisa Namulinda
ZCZhi-Long Chen
Zhi-Long Chen
Protoporphyrin IX (PpIX) is used as a photosensitizer in the photodynamic diagnosis (PDD) and photodynamic therapy (PDT) of cancer and is synthesized intracellularly from 5-aminolevulinic acid (5-ALA) precursors. Thirteen novel 5-ALA derivatives were designed and synthesized appropriately with tailored hydrophilicity and lipophilicity. The generation of PpIX was detected and their antitumor activity in vitro and in vivo was also investigated. It was shown that compounds 9b–c, 11b–c and 13a displayed a characteristic long wavelength absorption peak at 593 nm after 5 h incubation in mice fibrosarcoma S180 cells. After being exposed to 600 nm laser light irradiation, these compounds can inhibit cell proliferation in S180 cells in vitro. The growth of S180 cell tumors in Kunming mice was significantly inhibited by these compounds in vivo. Among these compounds, 13a has low dark toxicity and high phototoxicity, which makes it an effective and promising prodrug for PDT.

7 April 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
LWLaixing Wang
Laixing Wang
JLJianwei Li
Jianwei Li
JHJian-Yue Huang
Jian-Yue Huang
JLJianhong L. Li
Jianhong L. Li
LZLi-Jun Zhang
Li-Jun Zhang
ZCZhi-Long Chen
Zhi-Long Chen

14 September 2018 in Journal of Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
CCChao Chen
Chao Chen
GHGuosheng Han
Guosheng Han
YLYanan Li
Yanan Li
ZYZhijian Yue
Zhijian Yue
LWLaixing Wang
Laixing Wang
JLJianmin Liu
Jianmin Liu

1 April 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
MWMaomao Wang
Maomao Wang
HBHaiji Bo
Haiji Bo
DCDapeng Chen
Dapeng Chen
JMJiangxin Mao
Jiangxin Mao
ZMZong Miao
Zong Miao
LWLaixing Wang
Laixing Wang
Glioblastoma multiforme (GBM) is a highly aggressive brain tumor with limited treatment options and a poor prognosis. Its defining features include rapid proliferation, invasive capacity, and resistance to therapy. Bioinformatics analyses using TCGA and UALCAN datasets were conducted to assess MXRA8 and ELF3 expression and their association with patient survival. The expression levels were validated through qPCR and western blotting. Functional assays, including proliferation, migration, and invasion tests, were performed after silencing or overexpressing MXRA8 and ELF3. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays determined ELF3’s role in regulating MXRA8 transcription. An in vivo xenograft model was used to evaluate the effects of ELF3 and MXRA8 on tumor growth. MXRA8 expression was significantly elevated in GBM tissues and associated with reduced overall survival. Functional analyses revealed that MXRA8 knockdown inhibited oncogenic traits. Moreover, ELF3 was overexpressed in GBM tissues and positively correlated with MXRA8 expression. ChIP and dual-luciferase assays confirmed that ELF3 binds to the MXRA8 promoter and activates its transcription. Rescue experiments showed that MXRA8 overexpression could reverse the tumor-suppressive effects of ELF3 knockdown. In vivo, silencing ELF3 or MXRA8 inhibited tumor growth and proliferation. This study suggests that the ELF3-MXRA8 axis may be a critical driver of GBM progression, with ELF3 promoting tumor growth and invasion through transcriptional activation of MXRA8.

20 October 2010 in Academic Journal of Second Military Medical University
Verified
Journal Article
Closed access
SXShu Xu
Shu Xu
ZYZhi-Jian Yue
Zhi-Jian Yue
XZXiao-Ping Zhou
Xiao-Ping Zhou
JWJian-Jun Wang
Jian-Jun Wang
LWLaixing Wang
Laixing Wang
JLJian-Min Liu
Jian-Min Liu